United Kingdom Community Advisory Board

Home > Resources

We added new resources on 23 April:

Resources

A list of reports, briefings and presentations from UK CAB meetings.

This includes PowerPoints and PDFs hosted on this website and selected additional materials hosted on eternal websites. All of these have been presented or discussed at UK CAB meetings.

Describing the risk of an event and identifying risk factors PowerPoint: 336 Kb, Dr Caroline Sabin, Royal Free Hospital, April 2008
CROI 2008 feedback: understanding statistics in 3 studies PDF: 4 Mb, Simon Collins, HIV i-Base, April 2008
D:A:D position statement - abacavir, ddI and risk of heart attack PDF (external link): 63 Kb, D:A:D steering committee, February 2008
Immigration removal centres and HIV PowerPoint: 214 Kb, Joe Murry, Policy Officer, NAT, November 2007
Tests and monitoring in HIV infection PowerPoint: 558 Kb, Matt Williams, UK CAB, July 2007
Viral tropism PowerPoint: 592 Kb, Matt Williams, UK CAB, July 2007
Monitoring HIV infection and treatment in the era of HAART: 152 Kb, Dr Simon Edwards, Mortimer Market Centre, July 2007
Sisters are doing it for themselves: women, sexual health and HIV PDF (external link): 1.5 Mb, HIV Scotland, June 2007
BHIVA Audit 2006-7: survey of patient assessment and monitoring PDF (external link): 80 Kb, BHIVA, April 2007
Women, HIV and microbicides seminar report PDF (external link): 210 Kb, George House Trust and UK African Microbicides Working Group, March 2007
BHIVA standards project PowerPoint: 258 Kb, Hilary Curtis, November 2006
Human rights protection for people with HIV/AIDS PowerPoint (external link): 42 Kb, Hermione McEwen, Senior Solicitor, Greater Manchester Immigration Aid Unit, March 2006
UK guideline for the use of post-exposure prophylaxis for HIV following sexual exposure PDF (external link): 180 Kb, BASHH (International Journal of STD and AIDS), February 2006
Update on the neurological manifestations of HIV PDF (external link): 192 Kb, Justin McArthur, MBBS,MPH, Professor of Neurology and Epidemiology, Johns Hopkins University School of Medicine (PRN Notebook), September 2005
CAB steering group feedback PowerPoint: 164 Kb, Mark McPherson, UK CAB, November 2005
HIV Clinical trials at MRC Clinical Trials Unit PowerPoint: 1.3 Mb, Nick Paton, MRC Clinical Trials Unit, November 2005
Entry inhibitors and immunology PowerPoint: 116 Kb, Simon Collins, HIV i-Base, June 2005
Paediatric HIV care PowerPoint: 547 Kb, HIV i-Base, January 2005
BHIVA treatment guidelines 2005 PowerPoint: 84 Kb, Simon Collins, HIV i-Base, January 2005
BHIVA guidelines: what's new - new drugs PowerPoint: 620 Kb, Brian West, HIV Scotland, January 2005
Participating in an HIV vaccine trial PowerPoint: 212 Kb, Jo Robinson, EATG Vaccines Working Group, November 2004
HIV vaccine clinical trials: the need for community involvement PowerPoint: 448 Kb, Ken Legg, Imperial College of London, October 2004
Community participation in western Europe PowerPoint: 2.1 Mb, Emmanuel Trénado, EATG Vaccines Working Group, November 2004
Community participation in eastern Europe PowerPoint: 1.4 Mb, Dmitry Samoylov, Community of People Living with HIV/AIDS, Moscow, November 2004
European AIDS vaccine trials: an advocacy agenda: 148 Kb, Marion Zibelli, EATG Vaccine Working Group, November 2004
Statistics part 3: design of randomised controlled trials of treatments for HIV infection PowerPoint: 312 Kb, Dr Caroline Sabin, Reader in Medical Statistics and Epidemiology, Department of Primary Care and Population Sciences, August 2004
Introduction to basic vaccine technology PowerPoint: 416 Kb, Henry Graeme-Smith, May 2004
Topical microbicides PowerPoint: 3.4 Mb, Jo Robinson, THT in cooperation with the Global Campaign for Microbicides, May 2004
International AIDS Vaccine Initiative PowerPoint: 1.9 Mb, Maite Suarez, IAVA, May 2004
Community involvement in vaccine and microbicide research PowerPoint: 48 Kb, Julian Meldrum, May 2004
Thorny issues in HIV vaccine trials PowerPoint: 272 Kb , Saul Walker, Policy Advisor. IAVI, May 2004
Towards error-free HIV diagnosis: guidelines on laboratory practice PDF (external link): 332 Kb, JV Parry, PP Mortimer, KR Perry, D Pillay, M Zuckerman, for the Health Protection Agency HIV Laboratory Diagnosis Forum (Communicable Disease and Public Health), December 2003
Statistics part 2: hypothesis (significance) testing - more complex statistical methods PDF: 464 Kb, Dr Caroline Sabin, Reader in Medical Statistics and Epidemiology, Department of Primary Care and Population Sciences, November 2003
Statistics part 1: different types of study design - describing and displaying data PDF: 628 Kb, Dr Caroline Sabin, Reader in Medical Statistics and Epidemiology, Department of Primary Care and Population Sciences, November 2003
Enfuvirtide (T-20) PowerPoint: 5 Mb, Roche, Leroy Benons, Medical Advisor - HIV, Roche, May 2003
Access to HIV treatment: issues of working with HIV positive refugees and asylum seekers PowerPoint: 61 Kb, Linda McDonald MA MSc RN, April 2003
TB and HIV PowerPoint: 880 Kb, Dr Anton Pozniak, Chelsea and Westminster Hospital, March 2003
Hepatits C/HIV coinfection PDF: 748 Kb, Dr Ranjababu Kulasegaram, Guy's and St Thomas' Hospital, January 2003
Principles of care of the HIV-1 infected pregnant mother PowerPoint: 5.1 Mb, Dr Karen Beckerman, Assistant Professor of Obstetrics and Gynaecology, New York University, October 2002
HIV and subfertility PowerPoint: 338 Kb, Leila Frodsham, Clinical Research Fellow, Assisted Conception Unit, Chelsea and Westminster, October 2002
Tipranavir: design of the RESIST study PowerPoint: 468 Kb, Dr Kevin Curry, Boehringer Ingelheim, October 2002
Unique resistance profile of tipranavir PowerPoint: 696 Kb, Dr Kevin Curry, Boehringer Ingelheim, October 2002
Clinical aspects of treatment with tipranavir PowerPoint: 444 Kb, Dr Kevin Curry, Boehringer Ingelheim, October 2002
Understanding HIV-1 drug resistance testing PDF: 2.5 Mb, Professor Clive Loveday, International Clinical Virology Centre, August 2002
Salvage therapy PDF: 1.1 Mb, Dr Mike Youle, Royal Free Centre for HIV Medicine, August 2002
Methods of drug evaluation PowerPoint: 332 Kb, Tim Peto, MRC Clinical Trials Unit, May 2002
Gilead: tenofovir PDF: 328 Kb, Gilead Sciences, May 2002
Atazanavir PowerPoint: 834 Kb, BMS, February 2002
Informed consent and patient involvement in trials PowerPoint: 52 Kb, Norbert Tamm, Research Charge Nurse, Imperial College and St Mary�s Hospital, May 2002
d4T (stavudine, Zerit) extended release PowerPoint: 166 Kb, BMS, February 2002
DPC 083-201 (DuPont 083) PowerPoint: 914 Kb, Dr Nancy Ruiz, February 2002

Disclaimer | User agreement | Privacy | Contact us | About us